Lipid nanoparticles in anti-breast cancer drug delivery systems and drug-membrane interactions
Current anticancer drugs are plagued with lack of sustained effect and poor delivery. Many current studies focus on the use of drug carriers, particularly lipid nanoparticles as new drug delivery systems. In this study, a nanostructured lipid carrier (NLC) was formulated to serve as a carrier...
Saved in:
主要作者: | How, Chee Wun |
---|---|
格式: | Thesis |
語言: | English |
出版: |
2014
|
主題: | |
在線閱讀: | http://psasir.upm.edu.my/id/eprint/70806/1/FPV%202014%2012%20-%20IR.pdf |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Drug delivery systems based on iron oxide magnetite-layered double hydroxide nanoparticles for liver anti-cancer drugs
由: Ebadi, Mona
出版: (2021) -
Development of multifunctional drug delivery systems based on virus-like nanoparticles for cancer targeting drug delivery
由: Biabanikhankahdani, Roya
出版: (2017) -
Solid Lipid Nanoparticles As Drug
Carriers For Atovaquone
由: Mohtar, Noratiqah
出版: (2013) -
Formulation and characterization of beeswax/rosemary oil nanostructured lipid carrier for drug delivery system /
由: Farhanim Mohd Latif
出版: (2021) -
Development and evaluation of sustained drug delivery system of imatinib mesylate and its in-vitro effect in breast cancer cell lines /
由: Kadivar, Ali
出版: (2019)